Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The firm offers DecisionDx-Melanoma ...

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Castle Biosciences Inc (Symbol: CSTL), where a total of 2,062 contracts have traded so ...

Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The firm offers DecisionDx-Melanoma ...

Leerink Partners analyst Puneet Souda has maintained their bullish stance on CSTL stock, giving a Buy rating yesterday. Puneet Souda has given his Buy rating due to a combination of factors ...

Bài viết sẽ giúp bạn biết cách xoay rubik 6 mặt đơn giản nhất. Làm thế nào để giải khối Rubik? Nếu bạn đã từng nhìn vào khối Rubik và tự hỏi làm thế nào để mở khóa những bí mật của nó ...

Buy CSTL near 25.93 target 30.71 stop loss @ 25.86 Details The technical summary data tells us to buy CSTL near 25.93 with an upside target of 30.71. This data also tells us to set a stop loss @ 25.86 ...

Khách hàng có những thắc mắc nào đều sẽ được bác sĩ tại Gangwhoo giải đáp tận tình. + Bước 2: Khám sức khỏe tổng quát Khách hàng đồng ý thực hiện phẫu thuật thẩm mỹ nâng ngực sẽ được ...

Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...

Shares of NASDAQ CSTL opened at $26.62 on Wednesday. The company has a debt-to-equity ratio of 0.02, a quick ratio of 7.64 and a current ratio of 7.78. Castle Biosciences has a 1 year low of $16. ...

Leerink Partners analyst Puneet Souda maintained a Buy rating on Castle Biosciences (CSTL – Research Report) yesterday and set a price target of $50.00. The company’s shares closed yesterday ...